166 related articles for article (PubMed ID: 32604006)
1. Rate of elimination of γ-hydroxybutyrate from blood determined by analysis of two consecutive samples from apprehended drivers in Norway.
Årnes M; Bachs L; Sammarai MA; Jones AW; Høiseth G
Forensic Sci Int; 2020 Sep; 314():110374. PubMed ID: 32604006
[TBL] [Abstract][Full Text] [Related]
2. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
Busardò FP; Jones AW
Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
[TBL] [Abstract][Full Text] [Related]
3. Concentration-time profiles of gamma-hydroxybutyrate in blood after recreational doses are best described by zero-order rather than first-order kinetics.
Jones AW; Eklund A; Kronstrand R
J Anal Toxicol; 2009; 33(6):332-5. PubMed ID: 19653937
[TBL] [Abstract][Full Text] [Related]
4. Driving under the influence of zopiclone: Elimination between two consecutive blood samples.
Strand MC; Bleka Ø; Kristoffersen L; Høiseth G
Forensic Sci Int; 2023 Aug; 349():111764. PubMed ID: 37352736
[TBL] [Abstract][Full Text] [Related]
5. Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway.
Al-Samarraie MS; Karinen R; Mørland J; Stokke Opdal M
Eur J Clin Pharmacol; 2010 Oct; 66(10):987-98. PubMed ID: 20717656
[TBL] [Abstract][Full Text] [Related]
6. Driving under the influence of gamma-hydroxybutyrate (GHB).
Jones AW; Holmgren A; Kugelberg FC
Forensic Sci Med Pathol; 2008; 4(4):205-11. PubMed ID: 19291440
[TBL] [Abstract][Full Text] [Related]
7. Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases.
Jones AW; Holmgren A; Kugelberg FC
J Anal Toxicol; 2007; 31(9):566-72. PubMed ID: 18093415
[TBL] [Abstract][Full Text] [Related]
8. A two-sample approach to retrograde extrapolation of blood THC concentrations - Is it feasible?
Holman POS; Høiseth G; Bachs L; Thaulow CH; Vevelstad MS; Mørland J; Strand MC
Forensic Sci Int; 2023 Nov; 352():111833. PubMed ID: 37793282
[TBL] [Abstract][Full Text] [Related]
9. Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.
Liakoni E; Dempsey DA; Meyers M; Murphy NG; Fiorentino D; Havel C; Haller C; Benowitz NL
Psychopharmacology (Berl); 2018 Nov; 235(11):3223-3232. PubMed ID: 30232528
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.
Brenneisen R; Elsohly MA; Murphy TP; Passarelli J; Russmann S; Salamone SJ; Watson DE
J Anal Toxicol; 2004; 28(8):625-30. PubMed ID: 15538955
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers.
Dresen S; Kempf J; Weinmann W
Forensic Sci Int; 2007 Dec; 173(2-3):112-6. PubMed ID: 17383132
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of gamma-hydroxybutyrate (GHB) in motor vehicle drivers and its co-administration with amphetamine type substances (ATS) in Queensland, Australia (2011-2018).
Griffiths A; Hadley L
Forensic Sci Int; 2019 Oct; 303():109958. PubMed ID: 31542401
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.
Brailsford AD; Cowan DA; Kicman AT
J Anal Toxicol; 2012 Mar; 36(2):88-95. PubMed ID: 22337777
[TBL] [Abstract][Full Text] [Related]
14. Stability of γ-Hydroxybutyrate in Blood Samples from Impaired Drivers after Storage at 4°C and Comparison of GC-FID-GBL and LC-MS-MS Methods of Analysis.
Jones AW; Gladh SÅ; Windberg CN; Johansen SS
J Anal Toxicol; 2015 May; 39(4):294-9. PubMed ID: 25652881
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
[TBL] [Abstract][Full Text] [Related]
16. A potential new metabolite of gamma-hydroxybutyrate: sulfonated gamma-hydroxybutyric acid.
Hanisch S; Stachel N; Skopp G
Int J Legal Med; 2016 Mar; 130(2):411-4. PubMed ID: 26210636
[TBL] [Abstract][Full Text] [Related]
17. Detection of exogenous GHB in blood by gas chromatography-combustion-isotope ratio mass spectrometry: implications in postmortem toxicology.
Saudan C; Augsburger M; Kintz P; Saugy M; Mangin P
J Anal Toxicol; 2005; 29(8):777-81. PubMed ID: 16356334
[TBL] [Abstract][Full Text] [Related]
18. Urinary γ-hydroxybutyrate concentrations in 1126 female subjects.
Brailsford AD; Cowan DA; Kicman AT
J Anal Toxicol; 2010 Nov; 34(9):555-61. PubMed ID: 21073808
[TBL] [Abstract][Full Text] [Related]
19. Postmortem concentrations of gamma-hydroxybutyrate (GHB) in peripheral blood and brain tissue - Differentiating between postmortem formation and antemortem intake.
Thomsen R; Rasmussen BS; Johansen SS; Linnet K
Forensic Sci Int; 2017 Mar; 272():154-158. PubMed ID: 28111035
[TBL] [Abstract][Full Text] [Related]
20. A study of urinary endogenous gamma-hydroxybutyrate (GHB) levels.
Yeatman DT; Reid K
J Anal Toxicol; 2003; 27(1):40-2. PubMed ID: 12587682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
